In a retrospective analysis of the GOG-0218 trial, a modelled CA-125 ELIMination rate constant K (#KELIM) could identify patients who...

In the phase III #KEYNOTE-716 trial published in the Lancet, Adjuvant #pembrolizumab improved the clinical outcomes compared to placebo in...

In a pooled analysis of 12 randomised trials #SANDSTORM, to address the sequencing of androgen-deprivation therapy (ADT) with radiotherapy, concurrent/adjuvant...

The combination of ribociclib and endocrine therapy improved PFS in the first-line setting for premenopausal patients with aggressive ER-positive, HER2-negative...

In the phase 3 SWOG S1207 trial, the addition of 1 year of adjuvant Everolimus to adjuvant endocrine therapy failed...

In the phase 3 CAPItello-291 trial, presented at the SABCS, the addition of #capivasertib, an oral AKT inhibitor, to fulvestrant...

In a randomized phase III Indian study, the addition of low dose nivolumab to chemotherapy improved overall survival in patients...

In the phase 2 trial HYPORT-STS conducted at MD Anderson Cancer Center, moderately hypofractionated preoperative radiotherapy to patients with soft...

In the international phase III, EURO EWING 2012 trial, published in the Lancet, standard U.S. chemotherapy regimen improved the clinical...

In the phase 2 SERENA 2 trial, presented at the SABCS, treatment with the oral #SERD, #camizestrant monotherapy, resulted in...